![](/wp-content/uploads/2018/10/c3Wye8cORnmEfiopH9Qs.png)
$599
Lilly to Invest $400M in Diabetes Manufacturing
Lilly announced plans to invest $400M in its Lilly Technology Center campus in Indianapolis. The capital investment is said to include enhancements to existing manufacturing facilities that make Lilly insulin, expanding capacity for other marketed diabetes products, and initial capital investments for future medicines. Below, FENIX provides brief thoughts on Lilly’s investments including insights into which products are likely benefiting.